1. Home
  2. Launches

Tags : Launches

Sanofi Launches Tetraxim (DTaP-IPV) for Preschoolers in India

Sanofi Launches Tetraxim (DTaP-IPV) for Preschoolers in India

Tuba Khan October 1, 2020

Shots: Sanofi’s Tetraxim combines four vaccines into one and provides protection against four diseases – Diphtheria, Pertussis, Tetanus and Polio. The launch reduces the number of injections, increases comfort, and improves vaccination compliance for children Booster vaccines are designed to boost the immunity acquired during prior vaccination. With the launch, Sanofi currently protects school children […]Read More

Boston Scientific Launches ACURATE neo2 Aortic Valve System in Europe

Boston Scientific Launches ACURATE neo2 Aortic Valve System in Europe

Tuba Khan September 29, 2020

Shots:   The company has initiated a controlled launch of the ACURATE neo2 Aortic Valve System in the EU. The ACURATE neo2 valve system has expanded its indication for patients with aortic stenosis with no specified age or risk level The new system uses TAVI technology and builds on the clinical performance of the original ACURATE […]Read More

Philips Launches QuickClear Mechanical Thrombectomy System for Blood Clot Removal

Philips Launches QuickClear Mechanical Thrombectomy System for Blood Clot Removal

Tuba Khan September 25, 2020

Shots: Royal Philips has expanded its peripheral vascular disease portfolio with the launch of the QuickClear mechanical thrombectomy system. The system features an all-in-one aspiration pump and catheter for the removal of blood clots from the vessels of the peripheral arterial and venous systems The system eliminates the requirement for capital equipment or expensive accessories, […]Read More

Accord Launches Zercepac (biosimilar, trastuzumab) in the UK

Accord Launches Zercepac (biosimilar, trastuzumab) in the UK

Tuba Khan September 25, 2020

Shots: Accord launches Zercepac as s a biosimilar referencing Herceptin in the UK, following the EC’s approval in Jul’2020. The EC’s approval is based on a series of robust studies including comparative quality studies, pre/ clinical studies. The results confirmed the Zercepac’s bio-similarity, demonstrating comparable efficacy and safety to the Herceptin Zercepac is the first […]Read More

Roche Launches Elecsys Anti-SARS-CoV-2 S Test for COVID-19 Antibodies

Roche Launches Elecsys Anti-SARS-CoV-2 S Test for COVID-19 Antibodies

Tuba Khan September 18, 2020

Shots: Roche has launched Elecsys Anti-SARS-CoV-2 S Ab for markets accepting the CE Mark. The company has filed for US FDA’s EUA The test can quantitatively measure the level of Abs against SARS-CoV-2 in patients who have been exposed to the virus and can aid in characterizing a vaccine-induced immune response Using the Elecsys Anti-SARS-COV-2 […]Read More

True Digital Surgery and Aescula Launch Aesculap Aeos Robotic Digital Microscope in US

True Digital Surgery and Aescula Launch Aesculap Aeos Robotic Digital

Tuba Khan September 16, 2020

Shots: The robotic digital microscope enables surgeons to execute precision movements in neurosurgery, spine, and ear, nose, and throat operations, through a multi-axis robotic arm. The platform also offer potential improvements to safety and efficiency during surgeries as the heads-up display can be viewed while wearing PPE, which overcome the spread of COVID-19 The platform […]Read More

Cadila Launches Cadalimab (biosimilar, adalimumab) in India

Cadila Launches Cadalimab (biosimilar, adalimumab) in India

Tuba Khan August 31, 2020

Shots: Cadila has launched the adalimumab biosimilar under the brand name Cadalimab, referencing AbbVie’s Humira which is used to treat RA,PsA, AS and psoriasis The launch strengthens Cadila’s biosimilar portfolio as Cadalimab is the fourth biosimilar launched in the last 2mos. following Bevaro, Ritucad and NuPTH for cancer and osteoporosis Cadalimab is available in 40mg/0.8ml, […]Read More

FDC Launches Two Variants of Favipiravir for COVID-19 in India

FDC Launches Two Variants of Favipiravir for COVID-19 in India

Tuba Khan August 27, 2020

Shots: FDC has launched two variants of Favipiravir under the brand names PiFLU and Favenza to treat mild to moderate COVID-19 in India. The products will be available across the country Both the variant will be available at $0.74 (Rs. 55) /tablet. The DCGI had earlier approved the use of Favipiravir as an off-patent, oral […]Read More

Qiagen Launches QIAseq SARS-CoV-2 Primer Panel for Tracking COVID-19 Mutations and Strains

Qiagen Launches QIAseq SARS-CoV-2 Primer Panel for Tracking COVID-19 Mutations

Tuba Khan August 20, 2020

Shots: Qiagen’s QIAseq SARS-CoV-2 primer panel provides optimized, single-day workflows to prepare libraries for sequencing as researchers use NGS to track changes in the viral genome The two-step process uses advanced QIAseq technologies to conduct reverse transcription and cDNA synthesis from a viral RNA sample, then generate libraries compatible with Illumina sequencing platforms The solution […]Read More

Zydus Launches Cheapest Version of Remdesivir at $37.41 per Vial in India

Zydus Launches Cheapest Version of Remdesivir at $37.41 per Vial

Tuba Khan August 13, 2020

Shots: The company has launched Remdec at a price of $37.41 (Rs. 2800) for a 100mg lyophilized injection. The generic version is the most economical Remdesivir brand in India In Jun’2020, Zydus signed a non-exclusive agreement with Gilead to manufacture and commercialize Remdesivir for severe COVID-19 in India. The API of the therapy has been […]Read More

Copyright ©2020 PharmaShots | Powered by Octavus Consulting